Recognized as Place of research
15
Dec
Share
No Comments on Bispecific antibodies’ evolution Antibody, Monoclonal Antibodies
Bispecific antibodies’ evolution
The very first monoclonal antibody approved by the U.S. FDA (Food and Drug Administration) in 1997 ushered a new era in therapeutic applications for patients. A clinical breakthrough was acknowledged in the 1990s when there was the successful development of a humanized[…]
Read More11
Jun
Share
No Comments on Therapeutic Monoclonal Antibodies And Its Increasing Importance In The Healthcare Antibody
Therapeutic Monoclonal Antibodies And Its Increasing Importance In The Healthcare
Treatment of diseases arose with the concept of antibodies back in the 1890s, by Emil Adolf von Behring. In the further 1960s, there were structural characteristics describers, forward marking discovery of production methods of Monoclonal Antibodies (mAbs). The first mAb, muromonab-CD3, was[…]
Read More11
May
Share
No Comments on Advantages of Hybridoma vs Phage Display for Monoclonal Antibody Production Monoclonal Antibodies
Advantages of Hybridoma vs Phage Display for Monoclonal Antibody Production
What level of antibody affinity do you require? What will your project’s final application be? Do you have any limits in terms of time or money? If you’re deciding between hybridoma technology steps and phage display for a monoclonal antibodies production project[…]
Read More30
Aug
Share
No Comments on Use Of Monoclonal Antibody In Cancer Treatment Monoclonal Antibodies
Use Of Monoclonal Antibody In Cancer Treatment
What are monoclonal antibodies (MABs)? Monoclonal antibodies are proteins produced in the laboratory that can bind to body cells, even cancer cells. There are different types of monoclonal antibodies, or MABs, designed to carry out specific functions. At the same time, a[…]
Read More
